Known as Rejoyn, the treatment is a smartphone app that's designed to be used along with antidepressant medications. "Rejoyn represents a novel and exciting adjunctive treatment option to address ...

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

People in treatment for major depression now have another recovery option to try. Rejoyn, the first-ever app cleared by the ...